高效液相色谱法测定二甲苯磺酸拉帕替尼片有关物质

刘俊华,梁星晖,王斌荣

中国药学杂志 ›› 2013, Vol. 48 ›› Issue (8) : 644-648.

PDF(1008 KB)
PDF(1008 KB)
中国药学杂志 ›› 2013, Vol. 48 ›› Issue (8) : 644-648. DOI: 10.11669/cpj.2013.08.018
论著

高效液相色谱法测定二甲苯磺酸拉帕替尼片有关物质

  • 刘俊华,梁星晖,王斌荣
作者信息 +

Determination of Related Substances in Lapatinib Ditosylate Tablets by HPLC

  • LIU Jun-hua, LIANG Xing-hui,WANG Bin-rong
Author information +
文章历史 +

摘要

目的 建立测定二甲苯磺酸拉帕替尼片有关物质的高效液相色谱法。方法 采用Waters Xterra MS C18色谱柱(4.6 mm×250 mm,5 μm);以0.01 mol·L-1磷酸二氢钠溶液(用磷酸调节pH值至3.2)为流动相A,以乙腈为流动相B,梯度洗脱,流速1.0 mL·min-1;检测波长265 nm,柱温40 ℃。结果 拉帕替尼杂质A、拉帕替尼杂质2和拉帕替尼杂质1分别在0.02~8.08、0.02~8.26和0.02~8.29 mg·mL-1内线性关系良好, r≥0.999 9,定量限分别为1.0、1.4、2.1 ng,杂质高、中、低浓度的平均回收率(n=9)在100.2%~102.9%,RSD(n=9)在0.02%~0.66%,可以满足杂质分析的要求。结论 本方法简便、准确、专属性强,可定量测定二甲苯磺酸拉帕替尼片的有关物质。

Abstract

OBJECTIVE To establish a determination method of the related substances of lapatinib ditosylate tablets by HPLC. METHODS Waters Xterra MS C18 column (4.6 mm×250 mm, 5 μm) was selected; 0.01 mol·L-1 sodium dihydrogen phosphate solution (pH adjusted to 3.2 with phosphoric acid) was mobile phase A, acetonitrile was mobile phase B, and gradient elution was used at a flow rate of 1.0 mL·min-1. The detection wavelength was set at 265 nm, and the column temperature was 40 ℃. RESULTS Lapatinib Impurity A, LAPA-2 and LAPA-1 had good linearity in the range of 0.02-8.08, 0.02-8.26 and 0.02-8.29 mg·mL-1, respectively (r ≥ 0.999 9). The limits of quantitation (LOQ) were 1.0, 1.4, and 2.1 ng, respectively. The average recovery (n=9) was in the range of 100.2%-102.9%, and RSDs (n=9) were in the range of 0.02%-0.66%. CONCLUSION The method is simple, accurate, and specific and can quantitatively determine the related substances of lapatinib ditosylate tablets.

关键词

高效液相色谱法 / 二甲苯磺酸拉帕替尼片 / 拉帕替尼杂质A

Key words

HPLC / lapatinib ditosylate tablet / related substance / lapatinib impurity A

引用本文

导出引用
刘俊华,梁星晖,王斌荣. 高效液相色谱法测定二甲苯磺酸拉帕替尼片有关物质[J]. 中国药学杂志, 2013, 48(8): 644-648 https://doi.org/10.11669/cpj.2013.08.018
LIU Jun-hua, LIANG Xing-hui,WANG Bin-rong. Determination of Related Substances in Lapatinib Ditosylate Tablets by HPLC[J]. Chinese Pharmaceutical Journal, 2013, 48(8): 644-648 https://doi.org/10.11669/cpj.2013.08.018
中图分类号: R917   

参考文献

ZHAN Q. Lapatinib in breast cancer treatment . J Int Oncol(国际肿瘤学杂志),2007,34(8):596-599.
SFDA CDE.Technical guidelines for chemical drug impurities(化学药物杂质研究的技术指导原则).SFDA CDE,2007.http://www.cde.org.cn/attachmentout.do?mothed=list&id=161.
GlaxoSmithKline. . FDA,2010.http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/022059s3s6lbl.pdf.
PDF(1008 KB)

Accesses

Citation

Detail

段落导航
相关文章

/